News
These new supplemental products are offering similar benefits to drugs like Ozempic - but experts say it may be a placebo ...
A former college athlete, 51-year-old Charles never thought he'd have to worry about his weight. But football injuries and a ...
GLP-1 medications like Ozempic and Zepbound are transforming chronic disease and weight management, with perimenopausal women ...
A new study in mice has found that muscle loss associated with weight loss from GLP-1 medications like Ozempic may not be as ...
14h
MarketBeat on MSNTrump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli LillyThis week, drugmakers had a scare when President Trump threatened to levy tariffs of up to 250% on imported pharmaceuticals.
Inovia Pharmacy Yasser from Inovia Pharmacy joined Studio 17 host Kait Hill to discuss the rising popularity of GLP-1 ...
An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy ...
Eli Lilly reported second quarter earnings Thursday, a day after competitor Novo Nordisk missed earnings estimates by Wall ...
The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in treatment as well.
Linda Yaccarino is taking the top job at eMed Population Health, a telehealth startup focused on GLP-1 weight loss drugs, ...
GLP-1 Plus by Advanced BioNutritionals enters the spotlight with a patented dihydroberberine (DHB) formula in 2025, reflecting rising interest in GLP-1 alternatives and non-injection hunger support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results